Clinical Trials Browser

Completed × Esophageal Squamous Cell Carcinoma × Gemcitabine × Clear all

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01469598 2015-12-29

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

Phase 2 Completed

24 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma

NCT00012363 2012-06-14

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Phase 2 Completed

61 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Clinical Trials

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus